Keyphrases
Bleomycin
43%
Cancer of Unknown Primary
17%
Cancer Patients
49%
Chemotherapy
51%
Cisplatin
55%
Docetaxel
24%
Etoposide
34%
Germ Cell Tumor
59%
In Cancer
18%
Leydig Cell Dysfunction
19%
Metastasis
16%
Metastatic Castration-resistant Prostate Cancer (mCRPC)
41%
National Cohort Study
17%
Overall Survival
33%
Phase II Study
17%
Positron Emission Tomography
19%
Primary Tumor Site
19%
Progression-free Survival
18%
Resistance Training
17%
Small Cell Lung Cancer
17%
Stage I Seminoma
17%
Testicular Cancer
82%
Testicular Cancer Survivors
34%
Testicular Germ Cell Tumor
28%
Tumor
16%
Medicine and Dentistry
Biopsy Technique
16%
Bleomycin
38%
Castration Resistant Prostate Cancer
17%
Cisplatin
44%
Diseases
24%
Etoposide
37%
Germ Cell Cancer
74%
Interstitial Cell
19%
Malignant Neoplasm
40%
Metastatic Carcinoma
40%
Neoplasm
31%
Overall Survival
25%
positron emission tomographic scan
19%
Primary Tumor
23%
Resistance Training
17%
Seminoma
33%
Small Cell Lung Cancer
17%
Testis Cancer
100%
Pharmacology, Toxicology and Pharmaceutical Science
Bleomycin
26%
Castration Resistant Prostate Cancer
46%
Chemotherapy
61%
Cisplatin
51%
Diseases
17%
Docetaxel
31%
Etoposide
27%
Germ Cell Cancer
33%
Malignant Neoplasm
42%
Neoplasm
26%
Overall Survival
37%
Placebo
19%
Progression Free Survival
23%
Seminoma
15%
Testis Cancer
53%